Last updated 2026-06-18
- Acquired by SciSparc, Aug 2014
- Raised $1.5M funding round, Apr 2014
Total raised
$1.5M
Last: 2014-04
Stage
Acquired
Founded
2010
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Lara Pharm Ltd develops pharmaceutical-grade cannabinoids and related technology. By developing a way to mass-produce standardized cannabis-based prescription drugs,Lara Pharmseeks to eliminate the need for medical marijuana. The company has developed an inhaler that delivers a controlled dose of cannabinoids. Lara Pharm was acquired by Israeli Therapix Biosciences Ltd. (TASE: TRPH, formerly NasVax), back in August 2014.
Funding history · 1 round · $1.5M total
2014-04
$1.5M
Q&A
- What is Lara Pharm's primary focus?
- Lara Pharm Ltd develops pharmaceutical-grade cannabinoids and related technology, aiming to mass-produce standardized cannabis-based prescription drugs.
- When was Lara Pharm founded?
- Lara Pharm was founded in November 2010.
- What is Lara Pharm's current status?
- Lara Pharm was acquired by SciSparc in August 2014 and is currently inactive.
- Who acquired Lara Pharm?
- Lara Pharm was acquired by SciSparc in August 2014.
- What was the total amount raised by Lara Pharm before its acquisition?
- Lara Pharm raised a total of $1,500,000.
- Which investor participated in Lara Pharm's last funding round?
- SciSparc was an investor in Lara Pharm's last funding round in April 2014.
- How many employees did Lara Pharm have at the time of its acquisition?
- Lara Pharm had 1-10 employees.
- Who is the founder of Lara Pharm?
- Rita Alter is the CEO and Founder of Lara Pharm.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B
Tags
inhalationsleep-disorderscannabispharma-companiesglaucomaepilepsydiabetespain-reliefchemotherapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2010-11 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Acquired (Inactive) by SciSparc on Aug 2014 - closed due to acquisition |
Acquisitions & public offerings
Acquired by SciSparc 2014-08